Abstract
Background
Stress perfusion cardiovascular magnetic resonance (CMR) can be performed without rest perfusion for the quantification of ischemia burden. However, the optimal method of analysis is uncertain.
Methods
We identified 666 patients from Clinical Evaluation of MAgnetic Resonance imaging in Coronary heart disease (CE-MARC) with complete stress perfusion, rest perfusion, late gadolinium enhancement (LGE) and quantitative coronary angiography (QCA) data. For each segment of the 16-segment model, perfusion was visually graded during stress and rest imaging, with infarct transmurality assessed from LGE imaging. In the “Stress-LGE” analysis a segment was defined as ischemic if it had a subendocardial perfusion defect with no infarction. Rest perfusion was not used in this analysis. We compared the diagnostic accuracy of “Stress-LGE” analysis against QCA and the “Stress-rest” method validated in the original CE-MARC analysis. The diagnostic accuracy of the “Stress-LGE” method was evaluated with different thresholds of infarct transmurality used to define whether an infarcted segment had peri-infarct ischemia.
Results
The optimal “Stress-LGE” analysis classified all segments with a stress perfusion defect as ischemic unless they had >75% infarct transmurality (AUC 0.843, sensitivity 75.6%, specificity 93.1%, P<0.001). This analysis method has superior diagnostic accuracy to the “Stress-rest” method (AUC 0.834, sensitivity 73.6%, specificity 93.1%, P<0.001, P-value for difference=0.02). Patients were followed up for median 6.5 years for major adverse cardiovascular events (MACE), with the presence of inducible ischemia by either the “Stress- LGE” or “Stress-rest” analysis being similar and strongly predictive (Hazard Ratio 2.65, P<0.001, for both).
Conclusions
In this analysis of CE-MARC, the optimum definition of inducible ischemia was the presence of a stress-induced perfusion defect without transmural infarction. This definition improved the diagnostic accuracy compared to the “Stress-rest” analysis validated in the original study. The absence of ischemia by either analysis strategy conferred a favorable long-term prognosis.
Journal subject terms: Diagnostic Testing, Magnetic Resonance Imaging (MRI), Prognosis
Keywords: coronary artery disease, angina, myocardial perfusion imaging, magnetic resonance imaging, myocardial infarction, myocardial ischemia
Graphic abstract. Central Illustration.
Summary of “Stress-LGE” reanalysis of the CE-MARC study and its main findings. AUC area under the curve, LGE late gadolinium enhancement, MACE major adverse cardiac events, QCA quantitative coronary angiography.
Introduction
Stress perfusion cardiovascular magnetic resonance (CMR) has a Class 1 recommendation in the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guidelines for the evaluation and diagnosis of chest pain, particularly in those with intermediate-high risk or known obstructive coronary artery disease1. Conventionally perfusion imaging is performed first during stress with a short acting vasodilator such as adenosine, then again at rest, with segmental hypoperfusion at stress that normalizes at rest being diagnostic for ischemia.
Society for Cardiovascular Magnetic Resonance (SCMR) Standardized Protocols recommend that a minimum of 10 minutes should be left between stress and rest imaging to ensure the hemodynamic effects of adenosine have resolved2. A further 5-minute gap between rest perfusion and late gadolinium enhancement (LGE) imaging is advised. Removing rest perfusion imaging from the protocol can therefore save at least 5-7 minutes from the scan, and the standardized protocols advise that this can be done depending on institutional policy and experience.
The stress-rest ischemia definition has been validated in several studies including Clinical Evaluation of MAgnetic Resonance imaging in Coronary heart disease (CE-MARC), a prospective study of 752 patients who underwent stress perfusion CMR, myocardial perfusion scintigraphy using single-photon emission computed tomography (MPS-SPECT) and invasive coronary angiography3. In this study, ischemia, defined as a myocardial perfusion defect seen during hyperemia but not at rest, was found to have sensitivity of 77% and specificity of 92% compared to quantitative invasive angiography for the detection of significant coronary artery disease (CAD). A major strength of CE-MARC was that all patients underwent both CMR and invasive angiography, and that the CMR data was not used in clinical decision making.
There has been a recent trend to perform a stress-only protocol in which inducible ischemia is deemed to be present if there is a perfusion defect on stress perfusion imaging but no scar detected on LGE imaging2,4,5. Although removal of rest perfusion from the CMR exam has the potential to shorten the overall study time, its diagnostic accuracy against invasive coronary angiography is not known.
We hypothesized that when interpreting stress perfusion CMR, stress-only analysis has equivalent diagnostic accuracy to the stress-rest analysis which was validated in the original CE-MARC study. We also aimed to identify the optimum threshold of infarct transmurality at which segments with both infarction and stress-induced subendocardial hypoperfusion should be considered ischemic.
Methods
The data that support the findings of this study are available from the corresponding author upon reasonable request. The study design and primary analyses have been published previously3,6. In brief, patients with suspected stable angina were prospectively enrolled if they had at least one major cardiovascular risk factor and a cardiologist considered them to require further investigation. By protocol, all patients were scheduled to have CMR and MPS-SPECT in a randomized order, followed by invasive fluoroscopic coronary angiography within four weeks, regardless of the treating physician's chosen clinical pathway or prior imaging test results. After invasive angiography, the MPS-SPECT results could be made available on request to enable decision making about revascularization (blinding the treating clinician to this result was deemed unethical); however, CMR results were kept blinded. The study was conducted in accordance with the Declaration of Helsinki (2000) and approved by the United Kingdom National Research Ethics Service (05/Q1205/126); all patients provided informed written consent. Extended five-year follow-up was conducted with approval from the National Research Ethics Service (14/YH/0137) and under Section 251 of the National Health Service Act 2006 (14/CAG/1018).
CMR acquisition and analysis
CMR was performed on a 1.5T Philips Intera system (Philips, Best, The Netherlands) using a protocol that included stress perfusion (adenosine, 140μg/kg/min for ≥4 minutes), cine imaging, rest perfusion and LGE. CMR coronary imaging was previously shown to have inferior sensitivity and specificity compared to stress perfusion testing, and was therefore not used in this sub-analysis3,7–9. CMR analysis techniques from the original trial, which have previously been described in detail, were used in this analysis6. Scans were reported by paired readers with greater than ten years’ experience who were blinded to other tests and recorded by consensus.
Each segment within the 16-segment model6 during perfusion imaging was visually graded at stress and then rest (0 = normal, 1 = equivocal, 2 = subendocardial defect, 3 = transmural defect, 4 = transmural defect and wall thinned). LGE imaging was scored using the same 16-segment model, the presence of any infarction and its pattern described (subendocardial or transmural), and then categorized according to transmurality (0 = normal, 1 = <25%, 2 = 25-50%, 3 = 50-75%, 4 = 75-100%). Manual co-registration was used to localize infarction and ischemia to each of the 16-segments.
In the “stress-rest” analysis, as used in the original CE-MARC study, ischemia was defined as an increase in score of ≥2 in at least one segment between in at least one segment between stress and rest imaging. LGE imaging was not used in the diagnosis of ischemia in this analysis. For the “Stress-LGE” analysis, a segment was defined as ischemic if it had a stress perfusion score of ≥2 and no infarction (score 0) on corresponding LGE images (Figure 1). Rest perfusion imaging was not used in the diagnosis of ischemia in this analysis. Diagnostic accuracy was assessed by altering the definition of inducible ischemia according to the infarct transmurality (i.e. “Stress-LGE (>25%)”= stress perfusion score ≥2, LGE score ≥1, “Stress-LGE (>50%)”= stress perfusion score ≥2, LGE score ≥2 and “Stress-LGE (>75%)”= stress perfusion score ≥2, LGEscore ≥3). Ischemia burden was defined as the number of segments by each method that met the definition for inducible ischemia.
Figure 1.
Workflow for “Stress-LGE” and “Stress-rest” analysis. Arrow denotes number of minutes duration of the scan. LGE late gadolinium enhancement, LV left ventricle.
Invasive coronary angiography
Invasive fluoroscopic coronary angiography was analyzed by two experienced cardiologists blinded to the CMR and MPS-SPECT results. Based on the original trial, significant coronary artery disease was defined as ≥70% stenosis of a first order coronary artery measuring ≥2mm in diameter or left main stem stenosis ≥50% by quantitative coronary angiography (QCA) (QCAPlus, Sanders Data Systems, Palo Alto, California, USA).
Follow-up
Annual follow-up for five years was planned for all recruited patients. A detailed medical history since randomization was obtained from all hospital and general practitioners’ records, then cross-referenced to information obtained by direct telephone contact with each patient. Mortality and cause of death were obtained from the Office for National Statistics via the Health and Social Care Information Centre. Major Adverse Cardiac Events (MACE) was defined as the composite end point of cardiovascular death, myocardial infarction/acute coronary syndrome, unscheduled coronary revascularization or hospital admission for a cardiovascular cause (stroke/transient ischemic attack, heart failure and arrhythmia), in keeping with previous studies10,11. Unscheduled coronary revascularization was defined as any revascularization that occurred owing to clinical deterioration and excluded procedures that were planned based on the index coronary angiography results.
All clinical events were adjudicated by a clinical events committee that was blinded to any of the CMR results.
Statistical analysis
Continuous data are presented as mean ± standard deviation. Diagnostic accuracy of both methods against QCA was assessed by Receiver Operator Curve (ROC) analysis using the method described by Delong12. Hazard ratios for MACE were calculated by Cox proportional hazards regression.
Results
We identified 666 patients from CE-MARC with complete CMR stress perfusion, rest perfusion, LGE and QCA data. By QCA analysis, 262 (39.3%) cases were defined as having significant coronary stenosis.
Diagnostic accuracy versus angiography
By “Stress-LGE (>0%)” analysis, where all segments with LGE were considered non-ischemic, the area under the curve (AUC) was 0.825 with sensitivity 71.4% and specificity 93.4%. The diagnostic accuracy of “Stress-LGE” analysis could be improved with incremental LGE thresholds: “Stress-LGE (>25%)” AUC 0.835, “Stress-LGE (>50%)” 0.839 and “Stress-LGE (>75%)” AUC 0.843. The diagnostic accuracy of all these definitions was significantly better than “Stress-LGE (>0%)” (Table 1). By “Stress-rest”, as used in the original study, AUC was 0.834 with sensitivity 73.6% and specificity 93.1%. The only “Stress-LGE” analysis to have significantly better diagnostic accuracy compared to “Stress-rest” was “Stress-LGE (>75%)” with a difference in AUC of 0.009 (P=0.02). The diagnostic accuracy of “Stress-LGE (>75%)” was significantly better than “Stress-rest” in patients with prior myocardial infarction (MI) with difference in AUC of 0.02 (P=0.02). There were no other subgroups of patients, including male sex, co-morbidities or left ventricular systolic dysfunction (LVSD), where there was any significant difference in the diagnostic accuracy of “Stress-rest” and “Stress- LGE (>75%)” (Table 2).
Table 1. Comparison of Stress-LGE analysis methods according to the threshold at which a segment with infarction on LGE can be described as ischemic.
Any segment in the “Stress-LGE (>0%)” analysis with LGE was classified as infarcted and could therefore not be classified as ischemic. In the “Stress-LGE (>75%)” analysis only segments with >75% infarct transmurality were classified as infarcted and segments with 0-75% infarction could be classified as ischemic if there was inducible ischemia present on stress perfusion imaging. Comparisons in AUC between “Stress-LGE (>25%)”, “Stress-LGE (>50%)” and “Stress-LGE (>75%)” were non-significant. AUC area under the curve, LGE late gadolinium enhancement, N number.
| “Stress-rest” | “Stress-LGE (>0%)” | “Stress-LGE (>25%)” | “Stress-LGE (>50%)” | “Stress-LGE (>75%)” | |
|---|---|---|---|---|---|
| N | 666 | 666 | 666 | 666 | 666 |
| AUC | 0.834 (0.803-0.861) | 0.825 (0.794-0.853) | 0.835 (0.804-0.862) | 0.839 (0.809-0.866) | 0.843 (0.813-0.87) |
| P-value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
| Sensitivity (%) | 73.6 (37.9 - 78.9) | 71.4 (65.5-76.8) | 73.7 (67.9-78.9) | 74.8 (69.1-79.9) | 75.6 (69.9-80.7) |
| Specificity (%) | 93.1 (90.1 - 95.3) | 93.4 (90.7-95.8) | 93.3 (90.4-95.5) | 93.1 (90.1-95.3) | 93.1 (90.1-95.3) |
| Positive predictive value (%) | 87.3 (83.8 - 90.1) | 87.8 (83.1-91.3) | 87.7 (83.1-91.2) | 87.5 (82.9-91.0) | 87.6 (83.1-91.1) |
| Negative predictive value (%) | 84.5 (81.6-87.0) | 83.4 (80.6-85.9) | 84.5 (81.7-87.0) | 85.1 (82.2-87.5) | 85.5 (82.6-87.9) |
| Ischemia burden (segments) | 4.3 ± 2.8 | 3.9 ± 2.6 | 4.0 ± 2.7 | 4.3 ± 2.8 | 4.5 ± 2.6 |
| P-value vs “Stress-rest” | - | 0.15 | 0.76 | 0.08 | 0.02 |
| P-value vs “Stress-LGE (>0%)” | 0.03 | 0.01 | 0.004 |
Table 2. Diagnostic accuracy of “Stress-rest” and “Stress-LGE” strategies in subgroups of patients from CE-MARC.
ACS acute coronary syndrome, AUC area under the curve, BMI body mass index, CI confidence interval, LGE late gadolinium enhancement, LV left ventricular, LVEF left ventricular ejection fraction, LVMI left ventricular mass index, MI myocardial infarction, N number, SE standard error.
| N | “Stress-rest strategy” | “Stress-LGE (>75%) strategy” | Difference in AUC (95% CI) | P-value for difference in AUC | |||
|---|---|---|---|---|---|---|---|
| AUC (95% CI) | SE | AUC (95% CI) | SE | ||||
| All patients | 666 | 0.834(0.803 - 0.861) | 0.0150 | 0.843(0.813 - 0.870) | 0.0147 | 0.010(0.001 - 0.018) | 0.024 |
| Male | 410 | 0.839(0.800 - 0.873) | 0.0172 | 0.846(0.808 - 0.880) | 0.0170 | 0.007(-0.001 - 0.016) | 0.081 |
| Hypertension | 339 | 0.829(0.784 - 0.867) | 0.0213 | 0.832(0.788 - 0.871) | 0.0211 | 0.004(-0.004 - 0.011) | 0.317 |
| Diabetes | 84 | 0.766(0.661 - 0.852) | 0.0471 | 0.793(0.691 - 0.874) | 0.0452 | 0.027(-0.009 - 0.064) | 0.151 |
| Current smoker | 120 | 0.889(0.818 - 0.939) | 0.0311 | 0.900(0.831 - 0.947) | 0.0298 | 0.011(-0.010 - 0.032) | 0.317 |
| Obesity (BMI>30) | 263 | 0.843(0.794 - 0.885) | 0.0242 | 0.859(0.811 - 0.899) | 0.0233 | 0.016(-0.002 to 0.033) | 0.080 |
| Prior ACS | 55 | 0.775(0.642 - 0.877) | 0.0604 | 0.832(0.707 - 0.919) | 0.0552 | 0.057(0.004 to 0.111) | 0.036 |
| LVEF<50% | 93 | 0.905(0.827 - 0.956) | 0.0304 | 0.925(0.852 - 0.969) | 0.0276 | 0.020(-0.007 to 0.047) | 0.153 |
| LV Hypertrophy (LVMI>60g/m2) | 73 | 0.888(0.793 - 0.950) | 0.0376 | 0.888(0.793 - 0.950) | 0.0376 | 0.000(0.000 to 0.000) | 1.0 |
| Any MI on LGE | 124 | 0.826(0.748 - 0.888) | 0.0552 | 0.850(0.774 - 0.907) | 0.0544 | 0.023(0.003 to 0.044) | 0.022 |
Ischemia Burden
MI was present in 124 (18.6%) patients, where it affected 2.9±2.1 segments. The ischemia burden by “Stress-rest” was 4.3±2.8 segments and increased according to transmurality used in the definition of “Stress-LGE”: for “Stress – LGE (>0%)” 3.9 ± 2.6 segments, “Stress – LGE (>25%)” 4.0 ± 2.7 segments, “Stress – LGE (>50%)” 4.3 ± 2.8 and “Stress – LGE (>75%)” 4.5 ± 2.6 segments (Table 1).
Patient outcomes
Patients were followed up for a median of 6.8 years, during this time 109 (16.4%) patients suffered at least one MACE event. The Hazard Ratio for the presence of inducible ischemia by stress-rest, “Stress-LGE (>0%)” and “Stress-LGE (>75%)” were 2.65, 2.48, and 2.65 respectively (Table 3 and Figure 2) for MACE events (all significant at P<0.001). The presence of inducible ischemia was still associated with MACE by all definitions after correcting for the presence of LGE and the LVEF (Table 4).
Table 3. Univariable Cox regression of “Stress-rest” and “Stress-LGE” strategies compared to other CMR findings for the prediction of MACE.
Beta is the coefficient of the model. CI confidence interval, HR hazard ratio, LGE late gadolinium enhancement, LVEF left ventricular ejection fraction, MACE major adverse cardiovascular events, SE standard error.
| Covariate | Beta | SE | HR (95% CI) | P-value |
|---|---|---|---|---|
| Any ischemia by “Stress-rest” | 0.98 | 0.19 | 2.65 (1.82-3.87) | <0.001 |
| Any ischemia by “Stress-LGE (>0%)” | 0.91 | 0.019 | 2.48 (1.71-3.61) | <0.001 |
| Any ischemia by “Stress-LGE (>75%)” | 0.97 | 0.19 | 2.65 (1.82-3.86) | <0.001 |
| Ischemia burden by “Stress-rest” | 0.11 | 0.03 | 1.11 (1.05-1.12) | <0.001 |
| Ischemia burden by “Stress-LGE (>0%)” | 0.11 | 0.03 | 1.12 (1.5-1.19) | 0.0004 |
| Ischemia burden by “Stress-LGE (>75%)” | 0.10 | 0.03 | 1.10 (1.05-1.16) | <0.001 |
| Any infarction by LGE | 0.99 | 0.20 | 2.69 (1.82-3.98) | <0.001 |
| Infarction burden | 0.15 | 0.05 | 1.16 (1.06-1.27) | 0.002 |
| LVEF | -0.19 | 0.01 | 0.98 (0.96-1.01) | 0.98 |
Figure 2.
Cumulative MACE according to whether ischemia is present by “Stress-LGE (>75%)” or “Stress-rest” definitions. P-value by log-rank <0.001 for both. LGE late gadolinium enhancement, MACE major adverse cardiovascular events.
Table 4. Multivariable Cox regression of “Stress-rest” and “Stress-LGE” strategies corrected for LVEF and any infarction by LGE.
Beta is the coefficient of the model. CI confidence interval, HR hazard ratio, LGE late gadolinium enhancement, LVEF left ventricular ejection fraction, SE standard error.
| Covariate | Beta | SE | HR (95% CI) | P-value |
|---|---|---|---|---|
| Any ischemia by “Stress-rest” | 0.71 | 0.23 | 2.04 (1.31-3.12) | 0.002 |
| Any ischemia by “Stress-LGE (>0%)” | 0.65 | 0.22 | 1.92 (1.24-2.96) | 0.003 |
| Any ischemia by “Stress-LGE (>75%)” | 0.73 | 0.23 | 2.07 (1.31-3.26) | 0.002 |
| Ischemia burden by “Stress-rest” | 0.05 | 0.04 | 1.05 (0.98-1.12) | 0.17 |
| Ischemia burden by “Stress-LGE (>0%)” | 0.06 | 0.03 | 1.06 (0.99-1.14) | 0.09 |
| Ischemia burden by “Stress-LGE (>75%)” | 0.04 | 0.03 | 1.04 (0.97-1.11) | 0.25 |
Discussion
In this study we have performed a new exploratory analysis of data from 666 patients from CE-MARC with complete stress perfusion, rest perfusion, LGE and QCA data. The optimum definition of inducible ischemia was “Stress-LGE (>75%)”; the presence of a stress-induced perfusion defect without transmural infarction. This definition had higher diagnostic accuracy than both “Stress-LGE (>0%)” and “stress-rest”, the latter being validated in the original CE-MARC analysis.
In patients with MI, use of “Stress-rest” analysis as the threshold for classifying a segment as ischemic increased the ischemia burden compared with the “Stress-LGE (>0%)” definition, possibly reflecting the incorrect classification of sub-segmental peri-infarct ischemia as infarction in the latter. Finally, a positive test was associated with adverse outcomes on long term follow up regardless of whether “Stress-rest” or “Stress-LGE” analysis was used. Whilst these results support the use of a “Stress-LGE” image analysis it should be noted that the prevalence of prior MI (8%) and prior revascularization (5%) in CE-MARC were relatively low. Therefore, in complex patients with prior MI or revascularization a complete study including rest perfusion may still be needed.
Diagnostic accuracy of imaging protocols
In this study we have shown that removing rest perfusion from the imaging analysis does not adversely impact diagnostic accuracy measured against QCA, and in fact the diagnostic accuracy can be improved when only transmurally infarcted segments are classified as non-ischemic. The sensitivity and specificity were not significantly different between the twoanalysis methods (“Stress-rest” 73.6% and 93.1% and “Stress-LGE (>75%)” 73.6% and 93.1% respectively). The sensitivity in this analysis was lower than in the main trial where a positive test was defined by multiparametric findings including LGE and wall motion score3.
The data from CE-MARC is relatively unique in that all patients had both QCA and stress perfusion CMR. It is therefore ideal to validate the diagnostic accuracy of “Stress-only” imaging. However previous studies have examined the utility of “Stress-only” protocols. Rijlaarsdam-Hermsen et al. reported CMR findings from 642 consecutive patients with chest pain and a non-zero coronary artery calcium score4. They reported that “Stress-only” adenosine CMR was associated with a 91% sensitivity and a 99% specificity for the identification of coronary artery disease and showed incremental diagnostic benefit to coronary artery calcium scoring alone. However, invasive angiography was not mandated and was only performed if the stress-CMR was positive, introducing a major selection bias to the data. Additionally, a previous sub-study of CE-MARC, comparing quantitative myocardial perfusion assessments to visual analysis, found no benefit to inclusion of the rest perfusion data to the analysis for the detection of significant CAD13.
Refining diagnostic accuracy of stress-only imaging
Only 18.6% of patients in this study had MI by LGE imaging but the classification of infarcted segments made a large difference to both diagnostic accuracy and ischemia burden. Our data suggest that for the highest diagnostic accuracy in segments with both infarct and stress perfusion defects, only segments with transmural infarction should be classified as infarct, whereas all segments with sub-endocardial infarction and stress perfusion defects should be classified as ischemic. That this definition of “Stress-LGE” imaging outperformed “Stress-rest” imaging may reflect the higher spatial resolution of LGE imaging compared to rest perfusion imaging, and therefore the more accurate delineation of peri-infarct ischemia.
In the analysis we have only reported our findings segmentally. With advances in perfusion and LGE imaging, there are opportunities to improve the in plane spatial resolution and increase the number of slices acquired in stress imaging. These advances will allow differentiation of infarct and peri-infarct ischemia on a subsegmental level from a “Stress-only” scan leading to further improvements in diagnostic accuracy.
Villa et al. examined the impact of reporter experience on diagnostic accuracy. The main determinant of diagnostic accuracy was level of training. Rest-perfusion imaging did not improve diagnostic accuracy, although it did contribute to higher confidence in the results, particularly with the addition of quantitative perfusion maps which are particularly helpful in the exclusion of balanced ischemia14. Inclusion of rest-perfusion imaging could also still have a role when stress-perfusion imaging is affected by artefact, which could potentially be identified by inspection of rest perfusion datasets (e.g. persistent perfusion defects on stress and rest perfusion which appear artefactual and are unaccompanied by wall motion abnormalities or infarction).
Prognostic importance of a positive test
In this analysis of CE-MARC the presence of inducible ischemia by either “Stress-rest” or “Stress-LGE (>75%)” was associated with MACE over median 6.8 years follow up (with a hazard ratio for both of 2.65). There are limited data from other studies on the prognosticpotential of “Stress-only” imaging, but there are several studies which have shown the prognostic importance of inducible ischemia detected on “Stress-rest” CMR15–17.
SPINS (Stress CMR Perfusion Imaging in the United States) is a large multicenter retrospective registry of patients undergoing stress perfusion CMR for the evaluation of chest pain. SPINS included data from 2,349 patients followed up for median of 5.4 years18. The protocol did not mandate rest-perfusion imaging (although this was standard practice during the period of recruitment from 2008-2013). In SPINS the presence of inducible ischemia was associated with increased risk of MACE (3.30; 95% CI: 2.67–4.08, <0.001) which is comparable to the findings of our study.
Clinical benefits and shortcomings of a Stress-LGE imaging protocol
There are several benefits of a “Stress-LGE” imaging strategy. CMR scan time could potentially be significantly reduced if rest perfusion imaging is not acquired, particularly if other rapid image acquisition techniques are used19,20, therefore widening access, decreasing cost, and reducing waiting times. Given that stress CMR is recommended in both US chest pain1 and European Society of Cardiology chronic coronary syndrome21 guidelines, increased demand and streamlined protocols will likely increase capacity and availability. There is also the option to repeat stress imaging without concerns about total contrast dose if the first stress imaging is non-diagnostic.
The “Stress-LGE” does have potential pitfalls. One of the main uses of the rest perfusion imaging is to differentiate genuine hypoperfusion from artefact which is particularly important for less experienced CMR reporters. As spatial resolution of perfusion imaging islower than LGE imaging co-localization of slices can be challenging. Finally rest perfusion imaging is needed for quantitative perfusion analyses if microvascular perfusion reserve is to be calculated.
Study Limitations
In addition to the previously reported limitations of CE-MARC3,13, in this analysis we have performed the separate “Stress-rest” and “Stress-LGE” analyses from a single scan. We have used the original segmental analysis of CE-MARC for this study where the scan was reported in its entirety. It is possible therefore that unconscious bias may have affected the segmental reporting, although this may be offset by the consensus methodology used. Perfusion and LGE imaging were not matched for slice location although all 16 segments were covered by both imaging techniques. QCA was used as the reference standard in CE-MARC rather than fractional flow reserve (FFR), as this was standard practice at the time of data acquisition during CE-MARC which predated the major FFR trials. The proportion of patients in this analysis with evidence of prior MI on LGE imaging was relatively small at 19%, which might limit statistical power.
Conclusions
In this analysis of CE-MARC, the optimum definition of inducible ischemia was the presence of a stress-induced perfusion defect without transmural infarction. This definition improved the diagnostic accuracy compared to the “Stress-rest” analysis validated in the original study. AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR chest pain guidelines recommend stress perfusion CMR in patients with stable chest pain1, and these results are reassuring that the absence of ischemia by either analysis strategy confers favorable long-term prognosis.
Supplementary Material
Clinical Perspective.
Functional ischemia testing, specifically with stress perfusion cardiovascular magnetic resonance (CMR), is an established step in the evaluation of patients with chest pain. This study demonstrates that the rest perfusion imaging can safely be removed from the analysis without compromising imaging diagnostic and prognostic accuracy. For the highest diagnostic accuracy, all segments with stress induced subendocardial hypoperfusion without transmural infarction should be considered ischemic. Removal of rest imaging from the stress perfusion CMR examination can reduce study duration which could potentially reduce costs, increase throughput, and build capacity to increase access to CMR.
Sources Of Funding
This work was supported by the National Institute for Health Research (NIHR) Leeds Clinical Research Facility. The views expressed are those of the authors and not necessarily those of the National Health Service, NIHR, or the Department of Health. CE-MARC was funded by the British Heart Foundation who also fund both Dr Swoboda and Professor Plein (FS/CRA/22/23034 and CH/16/2/32089). Dr Matthews is funded by the NIHR. Dr Garg is funded by the Wellcome Trust.
Abbreviations And Acronyms
- ACS
Acute Coronary Syndrome
- AUC
Area Under the Curve
- BMI
Body Mass Index
- CE-MARC
Clinical Evaluation of MAgnetic Resonance imaging in Coronary heart disease
- CI
Confidence Interval
- CMR
Cardiovascular Magnetic Resonance
- FFR
Fractional Flow Reserve
- HR
Hazard Ratio
- LGE
Late Gadolinium Enhancement
- LV
Left Ventricle / Left Ventricular
- LVEF
Left Ventricular Ejection Fraction
- LVMI
Left Ventricular Mass Index
- LVSD
Left Ventricular Systolic Dysfunction
- MACE
Major Adverse Cardiac Events
- MI
Myocardial Infarction
- MPS-SPECT
Myocardial Perfusion Scintigraphy using Single-Photon Emission Computerized Tomography
- N
Number
- ROC
Receiver Operator Curve
- SCMR
Society for Cardiovascular Magnetic Resonance
- SE
Standard Error
- SPINS
Stress CMR Perfusion Imaging in the United States
- QCA
Quantitative coronary angiography
Footnotes
Disclosures
None
Contributor Information
Peter P. Swoboda, Email: p.swoboda@leeds.ac.uk.
Gareth D.K. Matthews, Email: gareth.matthews@uea.ac.uk.
Pankaj Garg, Email: p.garg@uea.ac.uk.
Sven Plein, Email: s.plein@leeds.ac.uk.
John P. Greenwood, Email: j.greenwood@leeds.ac.uk.
References
- 1.Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP, Conejo T, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144:e368–e454. doi: 10.1161/CIR.0000000000001029. [DOI] [PubMed] [Google Scholar]
- 2.Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson. 2020;22:17. doi: 10.1186/s12968-020-00607-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet Lond Engl. 2012;379:453–460. doi: 10.1016/S0140-6736(11)61335-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Rijlaarsdam-Hermsen D, Lo-Kioeng-Shioe M, van Domburg RT, Deckers JW, Kuijpers D, van Dijkman PRM. Stress-Only Adenosine CMR Improves Diagnostic Yield in Stable Symptomatic Patients With Coronary Artery Calcium. JACC Cardiovasc Imaging. 2020;13:1152–1160. doi: 10.1016/j.jcmg.2019.12.009. [DOI] [PubMed] [Google Scholar]
- 5.Nagel E, Chandrashekhar Y, Stress-Only CMR. JACC Cardiovasc Imaging. 2020;13:1296–1298. doi: 10.1016/j.jcmg.2020.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Greenwood JP, Maredia N, Radjenovic A, Brown JM, Nixon J, Farrin AJ, Dickinson C, Younger JF, Ridgway JP, Sculpher M, et al. Clinical evaluation of magnetic resonance imaging in coronary heart disease: the CE-MARC study. Trials. 2009;10:62. doi: 10.1186/1745-6215-10-62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kato S, Kitagawa K, Ishida N, Ishida M, Nagata M, Ichikawa Y, Katahira K, Matsumoto Y, Seo K, Ochiai R, et al. Assessment of Coronary Artery Disease Using Magnetic Resonance Coronary Angiography. J Am Coll Cardiol. 2010;56:983–991. doi: 10.1016/j.jacc.2010.01.071. [DOI] [PubMed] [Google Scholar]
- 8.Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H, Dill T, Larsson HBW, Flamm SD, Marquardt M, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008;29:480–489. doi: 10.1093/eurheartj/ehm617. [DOI] [PubMed] [Google Scholar]
- 9.Ripley DP, Motwani M, Brown JM, Nixon J, Everett CC, Bijsterveld P, Maredia N, Plein S, Greenwood JP. Individual component analysis of the multi-parametric cardiovascular magnetic resonance protocol in the CE-MARC trial. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson. 2015;17:59. doi: 10.1186/s12968-015-0169-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Greenwood JP, Ripley DP, Berry C, McCann GP, Plein S, Bucciarelli-Ducci C, Dall’Armellina E, Prasad A, Bijsterveld P, Foley JR, et al. Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical Trial. JAMA. 2016;316:1051–1060. doi: 10.1001/jama.2016.12680. [DOI] [PubMed] [Google Scholar]
- 11.Chowdhary A, Jex N, Thirunavukarasu S, MacCannell A, Haywood N, Almutairi A, Athithan L, Jain M, Craven T, Das A, et al. Prospective Longitudinal Characterization of the Relationship between Diabetes and Cardiac Structural and Functional Changes. Cardiol Res Pract. 2022;2022:6401180. doi: 10.1155/2022/6401180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–845. [PubMed] [Google Scholar]
- 13.Biglands JD, Ibraheem M, Magee DR, Radjenovic A, Plein S, Greenwood JP. Quantitative Myocardial Perfusion Imaging Versus Visual Analysis in Diagnosing Myocardial Ischemia: A CE-MARC Substudy. JACC Cardiovasc Imaging. 2018;11:711–718. doi: 10.1016/j.jcmg.2018.02.019. [DOI] [PubMed] [Google Scholar]
- 14.Villa ADM, Corsinovi L, Ntalas I, Milidonis X, Scannell C, Di Giovine G, Child N, Ferreira C, Nazir MS, Karady J, et al. Importance of operator training and rest perfusion on the diagnostic accuracy of stress perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson. 2018;20:74. doi: 10.1186/s12968-018-0493-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Lipinski MJ, McVey CM, Berger JS, Kramer CM, Salerno M. Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. J Am Coll Cardiol. 2013;62:826–838. doi: 10.1016/j.jacc.2013.03.080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Antiochos P, Ge Y, Steel K, Chen Y-Y, Bingham S, Abdullah S, Mikolich JR, Arai AE, Bandettini WP, Patel AR, et al. Evaluation of Stress Cardiac Magnetic Resonance Imaging in Risk Reclassification of Patients With Suspected Coronary Artery Disease. JAMA Cardiol. 2020;5:1401–1409. doi: 10.1001/jamacardio.2020.2834. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hamon M, Fau G, Née G, Ehtisham J, Morello R, Hamon M. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson. 2010;12:29. doi: 10.1186/1532-429X-12-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kwong RY, Ge Y, Steel K, Bingham S, Abdullah S, Fujikura K, Wang W, Pandya A, Chen Y-Y, Mikolich JR, et al. Cardiac Magnetic Resonance Stress Perfusion Imaging for Evaluation of Patients With Chest Pain. J Am Coll Cardiol. 2019;74:1741–1755. doi: 10.1016/j.jacc.2019.07.074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ibrahim E-SH, Frank L, Baruah D, Arpinar VE, Nencka AS, Koch KM, Muftuler LT, Unal O, Stojanovska J, Rubenstein JC, et al. Value CMR: Towards a Comprehensive, Rapid, Cost-Effective Cardiovascular Magnetic Resonance Imaging. Int J Biomed Imaging. 2021;2021:8851958. doi: 10.1155/2021/8851958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Raman SV, Markl M, Patel AR, Bryant J, Allen BD, Plein S, Seiberlich N. 30-minute CMR for common clinical indications: a Society for Cardiovascular Magnetic Resonance white paper. J Cardiovasc Magn Reson. 2022;24:13. doi: 10.1186/s12968-022-00844-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407–477. doi: 10.1093/eurheartj/ehz425. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



